Lutein 10 mg / omega-3 acid ethyl esters (USP) 800 mg / zeaxanthin 2 mg Oral Capsule
RxNorm 1087559

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1087559 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: lutein 10 mg / omega-3 acid ethyl esters (USP) 800 mg / zeaxanthin 2 mg Oral Capsule.

The following semantic concepts and normalized strings are associated with this clinical entity:

SCD
Lutein 10 mg / omega-3 acid ethyl esters (USP) 800 mg / zeaxanthin 2 mg Oral Capsule
Primary clinical definition
AUI:12342637
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SCD

Semantic Clinical Drug (SCD):
Lutein 10 mg / omega-3 acid ethyl esters (USP) 800 mg / zeaxanthin 2 mg Oral Capsule
(Atom ID: 12342637)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
lutein 10 MG / omega-3 acid ethyl esters (USP) 800 MG / zeaxanthin 2 MG Oral Capsule
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1087559
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12342637
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SCD
Semantic Clinical Drug (Ingredient + Strength + Dose Form)
Source Code
1087559
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN ACTIVATED
09/30/2020
Date the RxNorm atom was reactivated
RXN AI
{1087555} 484348
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{1087556} 39918
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{705208} 11359
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{1087555} 484348
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{1087556} 39918
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{705208} 11359
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AVAILABLE STRENGTH
10 MG / 800 MG / 2 MG
Available drug strengths listed in the order of ingredients from the drug
RXN BOSS FROM
{1087555} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1087556} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{705208} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN HUMAN DRUG
US
Drug available for use in Humans
RXN OBSOLETED
04/30/2020
Date the RxNorm atom became obsolete
RXTERM FORM
Cap
The RxTerm dose form name for this drug